The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

Nature Reviews. Microbiology
Gunilla B Karlsson HedestamRichard T Wyatt

Abstract

The ability to elicit broadly neutralizing antibody responses against HIV-1 is a crucial goal for a prophylactic HIV-1 vaccine. Here, we discuss the difficulties of achieving broad HIV-1 neutralization in the context of both the effective annual human influenza virus vaccine and the need to develop a pandemic influenza vaccine. Immunogen-design strategies are underway to target functionally conserved regions of the HIV-1 envelope glycoproteins, and similar strategies might be applicable to pandemic influenza virus vaccine development. Efforts to develop broadly neutralizing vaccines against either HIV-1 or influenza virus might establish a paradigm for future vaccines against highly variable pathogens.

References

Dec 1, 1975·Virology·H D KlenkJ Blödorn
Jan 1, 1990·Annual Review of Immunology·I A Wilson, N J Cox
Jan 1, 1987·Annual Review of Biochemistry·D C Wiley, J J Skehel
Jan 1, 1987·AIDS Research and Human Retroviruses·I WendlerG Hunsmann
Jan 1, 1995·Pharmaceutical Biotechnology·G OttG Van Nest
May 1, 1995·Journal of Virology·A McKnightP R Clapham
Mar 1, 1994·AIDS Research and Human Retroviruses·C L Kuiken, J Goudsmit
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·G J WeinerA M Krieg
Dec 23, 1999·The Pediatric Infectious Disease Journal·J S Abramson
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·D G MyszkaM L Doyle
Aug 31, 2000·Annual Review of Biochemistry·J J Skehel, D C Wiley
Feb 15, 2001·The Pediatric Infectious Disease Journal·S A Plotkin

❮ Previous
Next ❯

Citations

Apr 21, 2011·Plant Cell Reports·Ruth Elena Soria-GuerraSergio Rosales-Mendoza
Dec 14, 2011·Plant Cell Reports·Sergio Rosales-MendozaLeticia Moreno-Fierros
Aug 19, 2011·Nature·Laura M WalkerPascal Poignard
May 9, 2012·Nature Biotechnology·Barton F HaynesThomas B Kepler
Feb 28, 2009·Nature Protocols·Kenneth SmithPatrick C Wilson
Mar 26, 2009·Nature Reviews. Immunology·Susan Moir, Anthony S Fauci
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaoying ShenGeorgia D Tomaras
May 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Elisabetta BianchiPeter S Kim
Jan 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hugo MouquetMichel C Nussenzweig
Sep 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·John PietzschMichel C Nussenzweig
Nov 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hugo MouquetPamela J Bjorkman
Feb 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe JulienAndrew B Ward
Oct 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jiang ZhuLawrence Shapiro
Aug 4, 2010·The Journal of Experimental Medicine·John PietzschMichel C Nussenzweig
Sep 22, 2010·AIDS Research and Human Retroviruses·Takeo KuwataTatsuhiko Igarashi
Oct 28, 2010·Current Opinion in HIV and AIDS·Georgia D Tomaras, Barton F Haynes
Oct 28, 2010·Current Opinion in HIV and AIDS·Barton F HaynesGeorgia D Tomaras
Dec 24, 2010·Proceedings. Biological Sciences·Ben Adams, Alice Carolyn McHardy
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Julie Overbaugh, Lynn Morris
Nov 2, 2012·Clinical and Vaccine Immunology : CVI·Vincent J VendittoFrancis C Szoka
Jul 5, 2013·Journal of Virology·Reza KhayatAndrew B Ward

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.